BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences Products
News Nov 15, 2017
To date, there are 122 published articles altogether in this collection. This large collection is an earned honor for BOC Sciences after the past fifteen years of endeavors and fully demonstrates that products offered by BOC Sciences have received enough recognition among scholars and researchers, contributing to the advance of scientific explorations.
Published in Scientific Reports, ACS Applied Materials & Interfaces, Cells as well as dozens of other world-renowned professional scientific magazines and journals, many valuable findings are made concerning a wide range of research topics such as chemical synthesis, discovery of new and novel drugs to treat cancers, high blood pressure, heart disease, etc.
For example, celastrol purchased from BOC Sciences (Shirley, NY) was used as supplemental experimental procedures reagents in the research of obesity treatment. The relevant findings was compiled in an article titled Treatment of Obesity with Celastrol, which was published in Cell.
Founded in 2005 as a company specializing in small-molecule inhibitors, BOC Sciences has now expanded to offer a comprehensive range of chemical products and related solutions in the pharmaceutical industry including bioconjugation, biochemistry, biochemical and cellular analysis, compound synthesis and other clinical studies. “This means that customers now can find nearly whatever they want or need from BOC Sciences, which is the goal we are always striving for,” stated the Manager of Public Relations at BOC Sciences.
As always, BOC Sciences will continue to offer premium chemicals and meanwhile assist its customers with a complete suite of CRO services spanning the entire molecule development.
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE
Studying Ebola-Host Cell Interaction Helps Find Targets for Antiviral DrugsNews
In some ways, the Ebola virus operates like a vampire; only after it is politely invited in to a host cell does it take up the task of destroying everything in its path. In a new study researchers seek to elucidate quantitatively the biomechanical mechanism of Ebola-host cell interaction, providing potential new targets for antiviral drug development.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018